Free

MBC BioLabs Founders At Work Speaker Series: Nitrome

Event Information

Share this event

Date and Time

Location

Location

MBC BioLabs

953 Indiana Street

San Francisco, CA 94107

View Map

Event description

Description

MBC BioLabs Founders At Work Speaker Series

Irene Griswold-Prenner, PhD

Nitrome Biosciences: Discovery of a new class of enzyme(s), initially for treatment of Parkinson’s disease.

Irene Griswold-Prenner, CEO/CSO was previously a Cofounder and the CSO of Imago Pharmaceuticals. Imago, a privately held pharmaceutical company, engaged in development of drug candidates directed against JNK for fibrosis and neurodegenerative disease treatment. Imago acquired Elan Pharmaceuticals’ preclinical assets, including JNK, from which all assets were developed and partnered or sold to biotech or pharmaceuticals to continue their development into clinical trials. Dr. Griswold-Prenner previously led iPierian’s research efforts when value creation was realized for up to $725 million from the BMS acquisition of iPierian for IPN007, the first tau therapeutic antibody to begin human testing. IPN007 has now been purchased by Biogen for up to $1.4 billion and is progressing in Phase 2 studies for both PSP and AD. Previously Irene worked at Elan Pharmaceuticals, contributed to Alzheimer’s disease, Parkinson’s disease and Multiple Sclerosis Programs. She received her BA from Colorado University in Molecular, Cellular and Developmental Biology and Ph. D. from University of Chicago in Physiology and Cellular Pharmacology.

Share with friends

Date and Time

Location

MBC BioLabs

953 Indiana Street

San Francisco, CA 94107

View Map

Save This Event

Event Saved